Cite
Hu D, Ansari D, Pawłowski K, et al. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget. 2018;9(11):9789-9807doi: 10.18632/oncotarget.23929.
Hu, D., Ansari, D., Pawłowski, K., Zhou, Q., Sasor, A., Welinder, C., Kristl, T., Bauden, M., Rezeli, M., Jiang, Y., Marko-Varga, G., & Andersson, R. (2018). Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget, 9(11), 9789-9807. https://doi.org/10.18632/oncotarget.23929
Hu, Dingyuan, et al. "Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma." Oncotarget vol. 9,11 (2018): 9789-9807. doi: https://doi.org/10.18632/oncotarget.23929
Hu D, Ansari D, Pawłowski K, Zhou Q, Sasor A, Welinder C, Kristl T, Bauden M, Rezeli M, Jiang Y, Marko-Varga G, Andersson R. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma. Oncotarget. 2018 Jan 03;9(11):9789-9807. doi: 10.18632/oncotarget.23929. eCollection 2018 Feb 09. PMID: 29515771; PMCID: PMC5839402.
Copy
Download .nbib